Attached files
| file | filename |
|---|---|
| 10-K - Vicapsys Life Sciences, Inc. | v185945_10k.htm |
| EX-21 - Vicapsys Life Sciences, Inc. | v185945_ex21.htm |
| EX-32 - Vicapsys Life Sciences, Inc. | v185945_ex32.htm |
| EX-31.1 - Vicapsys Life Sciences, Inc. | v185945_ex31-1.htm |
| EX-31.2 - Vicapsys Life Sciences, Inc. | v185945_ex31-2.htm |
| EX-10.30 - Vicapsys Life Sciences, Inc. | v185945_ex10-30.htm |
| EX-10.28 - Vicapsys Life Sciences, Inc. | v185945_ex10-28.htm |
| EX-10.27 - Vicapsys Life Sciences, Inc. | v185945_ex10-27.htm |
| EX-10.29 - Vicapsys Life Sciences, Inc. | v185945_ex10-29.htm |
Exhibit
23
Consent
of Independent Registered Public Accounting Firm
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation in this Form 10-K of our report dated March 22,
2010, except for Note 19 as to which the date is May 13, 2010, relating to the
financial statements of SSGI, Inc. (f/k/a Phage Therapeutics International,
Inc.), as of December 31, 2009 and 2008 and for the years then ended and to all
references to our firm included in this Registration Statement.
/s/
Mallah Furman
Fort
Lauderdale, Florida